Last update 17 Apr 2025

Bifikafusp alfa

Overview

Basic Info

Drug Type
Antibody fusion proteins
Synonyms
Anti-EDB-IL2 antibody conjugate, Anti-EDB-interleukin-2 antibody conjugate, Darleukin
+ [4]
Action
inhibitors, agonists
Mechanism
EDB-FN inhibitors(Human fibronectin extra domain B inhibitors), IL-2R agonists(Interleukin-2 receptor agonists)
Originator Organization
Active Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Unresectable MelanomaPhase 2
United States
12 Jul 2024
Basal Cell CarcinomaPhase 2
Switzerland
02 Sep 2020
Non-Small Cell Lung CancerPhase 2
France
12 Mar 2019
metastatic non-small cell lung cancerPhase 2
Netherlands
01 Dec 2015
Neoplasm MetastasisPhase 2
Netherlands
01 Dec 2015
Diffuse large B-cell lymphoma recurrentPhase 2
Germany
21 Apr 2015
Diffuse large B-cell lymphoma refractoryPhase 2
Germany
31 Jul 2013
Malignant melanoma stage IVPhase 2
Germany
31 Jul 2013
Malignant melanoma stage IVPhase 2
Italy
31 Jul 2013
Metastatic melanomaPhase 2
Austria
01 Jun 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
25
wrlpcdlffg(aeolwovzpb) = sawtollpfn jbbfibtnan (fkfuvhxfdt )
-
20 May 2014
Not Applicable
32
jjocheuypf(hamcfvlftf) = hekuckrojc vgdekqtmxi (jangqzlqms )
Positive
20 May 2011
Phase 1/2
10
uqodfwloml(twrasdlmnp) = hxcqmpbphk sbnrvuhazh (yoqnmixtbz )
-
20 May 2009
Phase 1/2
33
fgzcqehbhy(ndxlhpkbev) = cdgyphyzov yclifgpinn (irbehlntpv )
-
20 May 2008
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free